Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 407.70
Bid: 406.40
Ask: 406.60
Change: 6.70 (1.67%)
Spread: 0.20 (0.049%)
Open: 408.90
High: 409.60
Low: 404.30
Prev. Close: 401.00
RTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding - Replacement

17 May 2016 17:06

RNS Number : 5228Y
Rentokil Initial PLC
17 May 2016
 

 

AMENDMENT

Changes made to boxes 20 and 22, amended figures are identified with an asterisk, and an explanation has been added in box 23.

 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

 

Notes: This form is intended for use by an issuer to make a RIS notification required by DTR 3.

 

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

 

Please complete all relevant boxes in block capital letters.

 

1. Name of the issuer

 

Rentokil Initial plc

 

2. State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance LR 9.8.6R(1) or(iii) a disclosure made in accordance with section 793 of the Companies Act (2006).

 

Pursuant to (i) above

 

3. Name of person discharging managerial responsibilities/director

 

i) Paul Cochrane (PDMR)

ii) Vanessa Evans (PDMR)

iii) Jürgen Hӧfling (PDMR)

iv) John Myers (PDMR)

v) Alain Moffroid (PDMR)

vi) Stewart Power (PDMR)

vii) Phill Wood (PDMR)

 

 

4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

 

Not applicable

 

5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

 

Pursuant to 3. above

 

6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares

 

Ordinary shares of 1 pence each

 

7. Name of registered shareholder(s) and, if more than one, the number of shares held by each of them

 

Not applicable

 

8 State the nature of the transaction

 

Awards under the Performance Share Plan - 2016 award

 

9. Number of shares, debentures or financial instruments relating to shares acquired

 

Not applicable

 

10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

 

Not applicable

 

11. Number of shares, debentures or financial instruments relating to shares disposed

 

Not applicable

 

12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) 

 

Not applicable

 

13. Price per share or value of transaction

 

Not applicable

 

14. Date and place of transaction

 

Not applicable

 

15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

 

Not applicable

 

16. Date issuer informed of transaction

 

Not applicable

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

 

17. Date of grant

 

11 March 2016 - Performance Share Plan award 2016

 

18. Period during which or date on which it can be exercised

 

12 March 2019 to 10 March 2026 (subject to performance conditions)

 

19. Total amount paid (if any) for grant of the option

 

Nil

 

20. Description of shares or debentures involved (class and number)

 

Ordinary shares of 1 pence each

 

PSP 2016 Award1

Type of award

Paul Cochrane

85,406*

Performance share plan

Vanessa Evans

188,205*

Performance share plan

Jürgen Hӧfling

178,297*

Performance share plan

Alain Moffroid

97,195*

Performance share plan

John Myers

217,488*

Performance share plan

Stewart Power

156,538*

Performance share plan

Phill Wood

204,582*

Performance share plan

 

Notes

1Two-thirds of the award relate to relative TSR performance targets and one-third to EPS performance targets.

 

The awards to Andy Ransom and Jeremy Townsend for 2016 were not made until after the 2016 AGM, at which resolutions to revise the Remuneration Policy and to adopt updated Performance Share Plan Rules were submitted for shareholder approval.

 

21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

 

Nil

 

22. Total number of shares or debentures over which options held following notification

 

Maximium award

Type of award

Paul Cochrane

85,406*

Performance share plan 2016

95,103

Performance share plan 2015

107,179

Performance share plan 2014

117,586

Performance share plan 2013

45,608

Performance share plan 2012 1

9,432

Performance share plan 2008 1

460,314

Total

Vanessa Evans

188,205*

Performance share plan 2016

196,720

Performance share plan 2015 2

384,925

Total

Jürgen Hӧfling

178,297*

Performance share plan 2016

228,069

Performance share plan 2015

406,366

Total

Alain Moffroid

97,195*

Performance share plan 2016

177,117

Performance share plan 2015

137,430

Performance share plan 2014

183,078

Performance share plan 2013

217,741

Performance share plan 2012 3

812,561

Total

John Myers

217,488*

Performance share plan 2016

217,759

Performance share plan 2015

154,116

Performance share plan 2014

199,848

Performance share plan 2013

64,961

Performance share plan 2008 1

854,172

Total

Stewart Power

156,538*

Performance share plan 2016

179,658

Performance share plan 2015

192,463

Performance share plan 2014

528,659

Total

Phill Wood

204,582*

Performance share plan 2016

238,284

Performance share plan 2015

255,267

Performance share plan 2014

165,980

Performance share plan 2013

64,734

Performance share plan 2012 1

928,847

Total

 

Notes

1 Unexercised but vested Performance share plan awards

2 Award on appointment under the Performance share plan 2015

3 Unexercised but vested compensatory share award on appointment under the Performance share plan 2012

 

23. Any additional information

 

This notification replaces the one dated 14 March 2016, which contained incorrect figures for the Performance share plan 2016 grant. The 2016 grant itself was made on 11 March 2016 on the correct basis, reflecting the amounts now shown correctly above, indicated with an asterisk.

 

24. Name of contact and telephone number for queries

 

Piotr Lasota, Company Secretarial Assistant - +44 (0)1276 607444

 

25. Name of authorised official of issuer responsible for making notification and date of notification

 

Daragh Fagan, Company Secretary - 17 May 2016

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHARMFTMBMBBIF
Date   Source Headline
15th Feb 20195:15 pmRNSHolding(s) in Company
1st Feb 20197:00 amRNSChange to Director's details
4th Dec 20187:00 amRNSDefined benefit pension scheme buy-in with PIC
20th Nov 20185:17 pmRNSHolding(s) in Company
16th Nov 20184:14 pmRNSHolding(s) in Company
24th Oct 20182:36 pmRNSDirector/PDMR Shareholding
18th Oct 20187:00 amRNSQ3 Trading Update
2nd Oct 201812:17 pmRNSBlock listing Interim Review
25th Sep 20187:25 amRNSDirector Declaration
13th Sep 20184:43 pmRNSDirector/PDMR Shareholding
29th Aug 20187:00 amRNSDirector/PDMR Shareholding
20th Aug 201812:44 pmRNSDirector/PDMR Shareholding
1st Aug 20183:12 pmRNSHolding(s) in Company
31st Jul 20187:00 amRNSInterim Results
27th Jul 20185:07 pmRNSHolding(s) in Company
5th Jul 20184:52 pmRNSHolding(s) in Company
5th Jul 201811:36 amRNSDirector Declaration
28th Jun 20184:10 pmRNSHolding(s) in Company
7th Jun 20185:16 pmRNSDirector Declaration
17th May 20184:12 pmRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSNotice of Capital Markets Days
9th May 20185:40 pmRNSResult of AGM
4th May 20184:27 pmRNSDirector/PDMR Shareholding
2nd May 201810:52 amRNSDirector/PDMR Shareholding
1st May 20186:00 pmRNSDirector/PDMR Shareholding
30th Apr 20185:48 pmRNSDirector/PDMR Shareholding
26th Apr 20183:24 pmRNSHolding(s) in Company
25th Apr 20184:50 pmRNSHolding(s) in Company
24th Apr 20183:55 pmRNSHolding(s) in Company
24th Apr 201810:53 amRNSHolding(s) in Company
20th Apr 20184:09 pmRNSDirector/PDMR Shareholding
19th Apr 20184:32 pmRNSHolding(s) in Company
19th Apr 20187:00 amRNSQ1 Trading Update
5th Apr 201812:57 pmRNSHolding(s) in Company
5th Apr 201811:06 amRNSAnnual Financial Report
4th Apr 20186:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20184:12 pmRNSBlock listing Interim Review
29th Mar 201811:55 amRNSTotal Voting Rights
27th Mar 20184:01 pmRNSHolding(s) in Company
27th Mar 201812:58 pmRNSAdditional Listing
8th Mar 20185:50 pmRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSFinal Results
27th Dec 20177:00 amRNSDirector/PDMR Shareholding
20th Dec 20173:40 pmRNSDirector/PDMR Shareholding
22nd Nov 20174:30 pmRNSHolding(s) in Company
17th Nov 20177:00 amRNSIssue of new EUR400m bond
13th Nov 20174:35 pmRNSHolding(s) in Company
13th Nov 20177:00 amRNSPurchase of Vector Disease Acquisition LLC
7th Nov 20174:14 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.